Author

Martin Krusche

h-index 3 View on Semantic Scholar

We have 1 of 18 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

CD19 CAR T cell therapy for treatment-refractory seropositive rheumatoid arthritis: a phase 1 trial.

CD19 CAR T cells showed acceptable short-term tolerability in patients with treatment-refractory RA, justifying further evaluation, and the primary endpoint was met, allowing advancement to phase 2.

F. Albach, Marie C. Rehm, M. Hütter-Krönke et al. · Nature Medicine · 0 citations